ArticleJournal of clinical medicine2020
Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea, February-May 2020.
Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic.Scientific reports · 2021Pooled it
- Improving case fatality ratio estimates in ongoing pandemics through case-to-death time distribution analysis.Scientific reports · 2025Article
- Evolution of the lethality due to SARS-CoV-2 in Spain according to age group and sex.Scientific reports · 2022Article
- Time-dependent risk of COVID-19 death with overwhelmed health-care capacity in Japan, 2020-2022.BMC infectious diseases · 2022Article
- Using trajectory modeling of spatio-temporal trends to illustrate disparities in COVID-19 death in flint and Genesee County, Michigan.Spatial and spatio-temporal epidemiology · 2022Article
- A novel method to monitor COVID-19 fatality rate in real-time, a key metric to guide public health policy.Scientific reports · 2022Article
- Estimating the risk of SARS-CoV-2 deaths using a Markov switching-volatility model combined with heavy-tailed distributions for South Africa.BMC public health · 2022Article
- Novel methods for estimating the instantaneous and overall COVID-19 case fatality risk among care home residents in England.PLoS computational biology · 2022Article
- COVID-19 and corticosteroids: a narrative review.Inflammopharmacology · 2022Review
- Development of Machine-Learning Model to Predict COVID-19 Mortality: Application of Ensemble Model and Regarding Feature Impacts.Diagnostics (Basel, Switzerland) · 2022Article
- Validation of Machine Learning Models to Predict Adverse Outcomes in Patients with COVID-19: A Prospective Pilot Study.Yonsei medical journal · 2022Article
- Analyzing the Use of Medicinal Herbs During the First Wave and Second Wave of COVID-19.Proceedings of the National Academy of Sciences, India. Section B · 2022Article
- Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.Epidemiology and infection · 2021Article
- Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data.BMC medical research methodology · 2021Article
- Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis.Health science reports · 2021Article
- Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021.International journal of environmental research and public health · 2021Article
- Regional Variability in COVID-19 Case Fatality Rate in Canada, February-December 2020.International journal of environmental research and public health · 2021Article
- Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020Article
- An Easy-to-Use Machine Learning Model to Predict the Prognosis of Patients With COVID-19: Retrospective Cohort Study.Journal of medical Internet research · 2020Article
- Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections.BMC medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundIn Korea, a total of 10,840 confirmed cases of COVID-19 including 256 deaths have been recorded as of May 9, 2020. The time-delay adjusted case fatality risk (CFR) of COVID-19 in Korea is yet to be estimated.
methodsWe obtained the daily series of confirmed cases and deaths in Korea reported prior to May 9, 2020. Using statistical methods, we estimated the time-delay adjusted risk for death from COVID-19 in Daegu, Gyeongsangbuk-do, other regions in Korea, as well as the entire country.
resultsOur model-based crude CFR fitted the observed data well throughout the course of the epidemic except for the very early stage in Gyeongsangbuk-do; this was partially due to the reporting delay. Our estimates of the risk of death in Gyeongsangbuk-do reached 25.9% (95% Credible Interval (CrI): 19.6%-33.6%), 20.8% (95% CrI: 18.1%-24.0%) in Daegu, and 1.7% (95% CrI: 1.1%-2.5%) in other regions, whereas the national estimate was 10.2% (95% CrI: 9.0%-11.5%).
conclusionsThe latest estimates of CFR of COVID-19 in Korea are considerably high, even with the early implementation of public health interventions including widespread testing, social distancing, and delayed school openings. Geographic differences in the CFR are likely influenced by clusters tied to hospitals and nursing homes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.